Latest Software Platforms News

Bridge SaaS Limited has exited its non-core investment in Brightside Disability Support, recouping its initial outlay and sharpening its focus on AI-driven disability services and robotics innovation.

Spacetalk has inked a strategic MVNO deal with TPG Telecom, aiming to improve mobile service economics and accelerate subscriber growth as it shifts towards a software-led business model.

Bravura Solutions plans to list on the London Stock Exchange's AIM market by late July 2026, aiming to tap into UK and European institutional investors while maintaining its ASX primary listing.

BCAL Diagnostics has locked in an additional $4.9 million under its existing convertible note facility alongside a $1.4 million R&D tax offset tranche, reinforcing its funding runway into FY2027 for early cancer detection test development.

Echo IQ has locked in a binding Heads of Agreement with Pro Medicus for a strategic A$20 million investment and a US commercial partnership to accelerate adoption of its AI-powered cardiac diagnostic platform.

CONNEQT Health has lodged an FDA Pre-Submission for SphygmoCor Cloud, aiming to shift its arterial health analytics from hardware to a scalable software platform with broad commercial potential.

NoviqTech Limited has clarified that its planned divestment of Non-Coralia assets was not foreseen during its Coralia acquisition and reflects a strategic pivot to biochar carbon removal, with leadership changes aligned to this refocus.

NoviqTech has agreed to sell its Carbon Central and Fuel Central assets for AUD 1 million, freeing up resources to expand its biochar carbon dioxide removal projects through Coralia.

Simble Solutions edges closer to $1 million in annual recurring revenue as major customer rollouts advance and its NanoSensor program moves forward along a structured development pathway.

Thrive Tribe Technologies (ASX:1TT) is issuing up to 1.5 billion free attaching options to recent placement participants, exercisable at $0.003 and expiring in 2029, potentially raising $4.5 million if fully exercised.

Vitrafy Life Sciences has teamed up with Vitalant Innovation Center to tackle the impending gap in red blood cell cryopreservation technology in the US, aiming to replace soon-to-be-discontinued legacy methods and potentially expand into other blood products.

Tetratherix Limited secures $15 million via institutional placement plus a capped $2 million share purchase plan at a 14% discount, aiming to fast-track manufacturing expansion and commercial partnerships.